REX-002 (Rexgenero)

N/A

Report date: 2023/01/12 15:31:30

Base Information

Drug NameREX-002 (Rexgenero)

Drug Alias NameREX-002

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsIschemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesRexgenero Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRexgenero Ltd

Active IndicationsN/A

Inactive IndicationsIschemia

Other Information

ATC CodeN/A